A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to millions of infections and deaths worldwide. As this virus evolves rapidly, there is a high need for treatment options that can win the race against new emerging variants of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kegler, Alexandra, Drewitz, Laura, Arndt, Claudia, Daglar, Cansu, Rodrigues Loureiro, Liliana, Mitwasi, Nicola, Neuber, Christin, González Soto, Karla Elizabeth, Bartsch, Tabea, Baraban, Larysa, Ziehr, Holger, Heine, Markus, Nieter, Annabel, Moreira-Soto, Andres, Kühne, Arne, Drexler, Jan Felix, Seliger, Barbara, Laube, Markus, Máthé, Domokos, Pályi, Bernadett, Hajdrik, Polett, Forgách, László, Kis, Zoltán, Szigeti, Krisztián, Bergmann, Ralf, Feldmann, Anja, Bachmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293748/
https://www.ncbi.nlm.nih.gov/pubmed/37383226
http://dx.doi.org/10.3389/fimmu.2023.1204543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293748/
https://www.ncbi.nlm.nih.gov/pubmed/37383226
http://dx.doi.org/10.3389/fimmu.2023.1204543

Ejemplares similares